PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-08

Date Title Company
08-Feb-2024 Intellipharmaceutics International Inc. Announces Stock Option Grant AccessWire
08-Feb-2024 Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results AccessWire
08-Feb-2024 Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results AccessWire
08-Feb-2024 Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage Businesswire
08-Feb-2024 TRYP THERAPEUTICS OBTAINS INTERIM ORDER FOR PLAN OF ARRANGEMENT AND PROVIDES DETAILS OF SHAREHOLDER MEETING Tryp Therapeutics Inc.
08-Feb-2024 Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting AccessWire
08-Feb-2024 MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
08-Feb-2024 Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2024 Businesswire
08-Feb-2024 X-FAB Fourth Quarter and Full Year 2023 Results Businesswire
08-Feb-2024 GE HealthCare and MedQuest Associates Collaborate to Provide Innovative Medical Device Technology and Digital Tools for Outpatient Imaging Centers Businesswire
08-Feb-2024 Paige Expands its AppLab Marketplace with Six New Digital Pathology Providers to Deliver a More Robust and Streamlined User Experience for Diagnosing Cancer Businesswire
08-Feb-2024 Samsung Launches New Women’s Health Online Resource at SMFM 2024 Pregnancy Meeting Businesswire
08-Feb-2024 Aizon Secures $20M in Series C Funding Led by NewVale Capital to Enhance Pharma Manufacturing Outcomes Businesswire
08-Feb-2024 Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product AccessWire
08-Feb-2024 Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product Newswire
08-Feb-2024 CorDx is Expected to Launch Groundbreaking 10-Minute Solution for Distinguishing COVID-19 and Flu A/B as Respiratory Cases Surge Across the U.S. AccessWire
08-Feb-2024 Unlearn Raises $50 Million Series C to Optimize Clinical Research With AI-Powered Digital Twin Technology Businesswire
08-Feb-2024 Linden Capital Partners and Ontario Teachers’ Pension Plan Launch Initiative Focused on Clinical Research Advancement Businesswire
08-Feb-2024 Resource Label Group announces new specialty business unit – RLG Healthcare Businesswire
08-Feb-2024 PulmoBioMed Aims to Revolutionise Asthma Diagnosis with Breakthrough Lung Test – PBM-Hale™ PulmoBioMed